Ocular Therapeutix
OCUL
OCUL
73 hedge funds and large institutions have $96.5M invested in Ocular Therapeutix in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.21% more ownership
Funds ownership: 53.41% → 53.62% (+0.21%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
33% less capital invested
Capital invested by funds: $144M → $96.5M (-$47.1M)
Holders
73
Holding in Top 10
2
Calls
$1.18M
Puts
$1.05M
Top Buyers
| 1 | +$3.06M | |
| 2 | +$1.42M | |
| 3 | +$763K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$245K |
| 5 |
SC
Sculptor Capital
New York
|
+$241K |
Top Sellers
| 1 | -$3.12M | |
| 2 | -$796K | |
| 3 | -$623K | |
| 4 |
CI
Cowen Inc
New York
|
-$456K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$371K |